Evaluating the clinical significance of KIAA1199 expression in locally advanced gastric cancer May 5, 2020
IPN-60090: a GLS1 inhibitor for the oral treatment of KEAP1/NFE2L2-mutant NSCLC and ASNS-low HGSOC May 4, 2020
Preclinical and preliminary phase I results presented for menin/MLL interaction inhibitor SNDX-5613 May 4, 2020
RSS